MCK stock forecast
Our latest prediction for McKesson Corp.'s stock price was made on the May 30, 2019 when the stock price was at 123.85$.
In the short term (2weeks), MCK's stock price should outperform the market by 0.23%. During that period the price should oscillate between -4.14% and +5.04%.
In the medium term (3months), MCK's stock price should outperform the market by 0.25%. During that period the price should oscillate between -10.07% and +13.73%.Get email alerts
About McKesson Corp.
McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
At the moment the company generates 217440M USD in revenues.
On its last earning announcement, the company reported a profit of 3.09$ per share.
The book value per share is 47.09$
Three months stock forecastMay 30, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|